Discovery and Functional Characterization of a Recombinant Fragment of Human Collagen Type XVII
Journal of Agricultural and Food Chemistry · 2025
DOI: 10.1021/acs.jafc.5c00277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, 2025. Verfasst von Lianhua Piao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Bioinformatics and Medical Engineering, Jiangsu University of Technology, Changzhou 213001, China. Hauptthemen laut MEDLINE: Non-Fibrillar Collagens, Autoantigens. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Youth Talent Development Plan of Changzhou Health Commission, Youth Science and Technology Talent Program of Changzhou Health and Family Planning Commission.
Abstract (Originalsprache)
COL17A1 is predominantly expressed in skin epithelial cells and primarily localized within hemidesmosomes. It plays an essential role in epidermal-dermal attachment. Consequently, a recombinant human-like COL17A1 protein (rhCOL17) with low molecular weight and high biocompatibility presents a promising and competitive biomaterial. The aim of this study is to gain more insight into the biological functions and underlying molecular mechanisms of rhCOL17, which primarily consists of amino acid residues Gly659-Leu720. Using a combination of surface plasmon resonance (SPR) and liquid chromatography-tandem mass spectrometry (LC-MS/MS), we identified the interacting partner proteins of rhCOL17 in HaCaT cells. These included several collagens, integrins, and cell polarity proteins. Upon rhCOL17 treatment, the expression levels of laminin-332, integrin β1, and the cell polarity proteins PAR-3 and PAR-6B were upregulated, while the PRKCZ, AKT, and TGF-β1 signaling pathways were activated. Furthermore, rhCOL17 was found to promote cell proliferation and mitigate UV radiation-induced damage, partly by modulating these interacting proteins and their associated signaling pathways. Additional analyses using AlphaFold2 and molecular dynamics simulations revealed that the rhCOL17 peptide bound stably and tightly to the canonical ligand-binding site between the integrin α3 and β1 subunits. These findings highlight the potential versatility and applications of rhCOL17 in the field of antiaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Bioinformatics and Medical Engineering, Jiangsu University of Technology, Changzhou 213001, China.
- Primary Biotechnology Co., Ltd., Changzhou 213125, China.
- TRAUTEC Medical Technology CO., Ltd., Changzhou 213000, China.
- Proya Cosmetics Co., Ltd, Hangzhou 310000, China.
- Department of Orthopaedics, The Third Affiliated Hospital of SooChow University, Changzhou, Jiangsu 213000, China.
- Institute of Plant Protection, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China.
ORCID-Profile: Lianhua Piao, Shan Chang, Ren Kong
Förderung
- National Natural Science Foundation of China
- Youth Talent Development Plan of Changzhou Health Commission
- Youth Science and Technology Talent Program of Changzhou Health and Family Planning Commission
Zitieren
APA
Piao, L., Li, J., Li, X., Su, Y., Yuan, X., Chang, S., Cheng, X., Fu, S., & Kong, R. (2025). Discovery and Functional Characterization of a Recombinant Fragment of Human Collagen Type XVII. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.5c00277
Vancouver
Piao L, Li J, Li X, Su Y, Yuan X, Chang S, et al. Discovery and Functional Characterization of a Recombinant Fragment of Human Collagen Type XVII. Journal of Agricultural and Food Chemistry. 2025. doi:10.1021/acs.jafc.5c00277
BibTeX
@article{Piao2025,
author = {Piao, Lianhua and Li, Jiajia and Li, Xiaojing and Su, Yangyang and Yuan, Xiaofeng and Chang, Shan and Cheng, Xinyi and Fu, Shengwei and Kong, Ren},
title = {Discovery and Functional Characterization of a Recombinant Fragment of Human Collagen Type XVII},
journal = {Journal of Agricultural and Food Chemistry},
year = {2025},
doi = {10.1021/acs.jafc.5c00277}
}
EUVIMED